Abstract OBJECTIVE: To study the expression of nm23-H1 gene in children with acute lymphoblastic leukemia (ALL) and the relationship between nm23-H1 expression and immunophenotype. METHODS: nm23-H1 expression was measured by semiquantitative RT-PCR in children with ALL (newly diagnosed, n=40; remission, n=32; relapse, n=16; refractory, n=3). Twenty normal children served as the control group. The relationship between nm23-H1 expression and immunophenotype was evaluated. RESULTS: The expression of nm23-H1 in the newly diagnosed ALL group was significantly higher than that in the control (P<0.01) and the remission groups (P<0.01). There was no difference in the nm23-H1 expression between the remission and the control groups. The expression of nm23-H1 in the relapse group was significantly higher than that in the control (P<0.01) and the remission groups (P<0.01), and similar to that in the newly diagnosed ALL group. The three children with refractory ALL had higher nm23-H1 expression. Both the positive rate and expression of nm23-H1 in children with T-lineage ALL were higher than in children with B-lineage ALL (P<0.05). CONCLUSIONS: The expression level of nm23-H1 varies with the stages of ALL. Newly diagnosed, relapsed and refractory ALL children have higher nm23-H1 expression. High nm23-H1 expression may be associated with a poor prognosis and relapse. A higher expression of nm23-H1 in children with T-ALL may be contributed to a low remission rate and a poor prognosis.［Chin J Contemp Pediatr, 2009, 11 (11):881-884］
NING Fang,CAI Shao-Jiang,ZHANG Tong-Juan et al. Expression of nm23-H1 gene in childhood acute lymphoblastic leukemia and the relationship between nm23-H1 expression and immunophenotype[J]. 中国当代儿科杂志, 2009, 11(11): 881-884.
NING Fang,CAI Shao-Jiang,ZHANG Tong-Juan et al. Expression of nm23-H1 gene in childhood acute lymphoblastic leukemia and the relationship between nm23-H1 expression and immunophenotype[J]. CJCP, 2009, 11(11): 881-884.
［4］Yokoyama A, Okabe-Kado J, Wakimoto N, kobayashi H, Sakashita A, Maseki N, et al. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies ［J］.Blood, 1998, 91(6):1845-1851.
［6］Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, et al. Evidence of a novel gene associated with low tumor metastatic potential ［J］.J Natl Cancer Inst, 1988, 80(3):200-204.
［7］Kapoor S. nm23-H1 expression and its role in the evolution of non-gastrointestinal malignancies ［J］.World J Gastroenterol, 2009,15(4):506-507.
［8］Korabiowska M, H-nig JF, Jawien J, Knapik J, Stachura J, Cordon-Cardo C, et al. Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity ［J］. In Vivo, 2005, 19(6):1093-1096.
［9］Yaguchi H, Ohkura N, Tsukada T, Yamaguchi K. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23 ［J］. J Biol Chem, 2002, 277(41):38197-38204.
